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Abstract  
 We aim to Provide facts about the vaccination coverage for combined 
vaccines such as MMR (Measles, Mumps and Rubella) and DTP 
(Diphtheria, Tetanus, Pertussis) containing vaccines in use in Albania during 
the last 10 years, in order to confirm the stability of immunization program. 
One of the reasons for coverage improvement is the use of one or two-dose 
vials for the administration of MMR vaccine, enabling the vaccination of 
children at any time, without the need of gathering them on certain days 
when the multi-dose vaccine vials are opened. In the last three years, 
according to WHO recommendations, it was noted that vaccination coverage 
with three doses containing DTP is at sustainable levels, always above 95%, 
but for our country this value goes sometimes above 98%. As for the use of 
pentavalent vaccine, from 2008, DTP-HepB-Hib, also the coverage of 
Hepatitis b vaccine is always at upper levels due to its use on 5 in 1 
combination. The application of this vaccine was associated with the use of 
one dose vial administration, therefore one vaccine to a child. Immunization 
coverage for vaccines with measles component remains at very high levels 
for both doses of vaccine, more then 95%. Immunization coverage for 
vaccines with DTP component exceeds 95% rate at country level, for each 
district it exceeds 95% and it reaches the value of 98.5% for the last two 
years. During the last years the vaccine coverage is increased significantly as 
a result of using combined vaccine of DTP-HepB -Hib. The use of one dose 
vials has played an important role on sustaininig and increasing vaccination 
coverage. 
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Introduction 
 In Albania, the measles vaccine has been in regular use since 1971 as 
a single antigen. Due to the epidemic outbreak of 1970-71, a mass 
vaccination, with the imported B55 vaccine, was urgently taken for the first 
time in Albania, for all groups of children born in the period 1956-1970. In 
1971 induced routine vaccination against measles was introduced in the 
national immunization schedule for all new births that would follow and in 
1977 measles vaccine began to be produced even in the country.  
 In 1992, domestic production of B55 vaccine was interrupted, being 
replaced by the imported Schwarz vaccine. Since January 200, Albania has 
introduced the bi-valent measles and rubella vaccine in the compulsory 
vaccination calendar (Kakarriqi, 2002) giving the child a basic dose on the 
12th month of birth and the booster dose at age of 5. Mumps component was 
added to the National Immunization Program since January 2005 with the 
introduction of the three-valent vaccine, which is still in use in Albania 
today. 
 Measles is considered as a disease that could disappear because of a 
single serotype, effective vaccine, lack of human natural reservoirs and high 
clinical expression of the disease. For years an attempt has been made to 
eliminate measles through continuous vaccination to prevent its recurrence 
achieving so the “herd” immunity. Global eradication will be based on the 
successful elimination in all countries. 
 The most recent assessment by WHO for measles vaccine coverage 
(Figure 1) shows that globally the values are over 90% mostly in American 
and European regions. Much work remains to be done in order to increase 
vaccine coverage in the African region and partly in the Asian one (WHO, 
2016). 
 
Figure 1. Global Immunization coverage for vaccines containing measles 
Source: (WHO / UNICEF, 2013) 
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 Regarding tetanus, diphtheria and pertussis are diseases that might be 
very serious and caused by bacteria. Tetanus enters the body through the 
cracks, deep scratches and wounds, while diphtheria and pertussis are spread 
from person to person through coughing or sneezing. (CDC, 2012) 
 
Figure 2. DTP3 vaccine coverage (diphtheria, tetanus anatoksina and pertus, with three 
doses) in children, 2011. Source (WHO database, 2012) 
 
Materials and Methods 
 Routine levels of vaccination coverage indicate the vaccination 
program performance and provide an overview of immunity in the 
population. Immunization coverage is usually assessed on the basis of the 
percentage of children who have received a certain number of recommended 
vaccine dose during the first year of life. In the same way, the vaccination 
coverage is also evaluated for the recommended vaccines doses for 
revaccination (reminder immune). This vaccination coverage is nothing but a 
report of the number of children vaccinated versus the number of children 
scheduled for vaccination. The reported covarage data taken from the 
vaccination centers are aggregated to higher levels by providing values at the 
district, prefecture and national levels. (WHO, 2010) 
 In this study, we tried to provide facts about the vaccine coverage for 
combined vaccines such as MMR and DTP containing vaccines in use in 
Albania during the last 10 years, in order to confirm the stability of 
immunization program. 
 The percentage of vaccine coverage for each vaccination 
(immunization) indicator in all districts of the country during the years 2003-
2013, for each antigen obtained in the study. 
 Immunization coverage in percentage is calculated by the formula: 
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𝐼𝑚𝑚𝑢𝑛𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒(%)= 𝑇ℎ𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑎𝑐𝑐𝑖𝑛𝑎𝑡𝑒𝑑 𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛 
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑐ℎ𝑖𝑙𝑑𝑟𝑒𝑛 𝑠𝑐ℎ𝑒𝑑𝑢𝑙𝑒𝑑 𝑓𝑜𝑟 𝑣𝑎𝑐𝑐𝑖𝑛𝑎𝑡𝑖𝑜𝑛  𝑥 100 
 
Results: 
 In the context of eliminating measles (Kakarriqi and Bino, 2002), an 
important factor for vaccine coverage is its level over 95% at country level 
and at the district level over 90%, or vaccination coverage 90% for two doses 
of vaccine containing component of measles, for all children until 2015.  
 MR vaccine was used in the years 2003-2004 and then, from 2005 
until now the MMR vaccine has been used  in the national immunization 
calendar (Bino et al, 2003). 
 Graphically this coverage is presented in the following graph (1) 
where it is obvious that this coverage for both doses exceeds levels of 95%, 
except for 2006, during which the national program of vaccination was faced 
with a shortage of this vaccine globally and exactly in this year two measles 
outbreaks occurred, mainly in the Roma population of Saranda and Elbasan 
districts.  
 Furthermore, a reason for the improvement of this coverage is the use 
of one dose bottles administration for MMR vaccine, enabling the 
vaccination of children at any time, without the need of collecting them on 
certain days when the vaccine bottles are opened. 
Graph 1. Immunization coverage with measles vaccines in years.* Mumps component 
(parotit) was introduced in 2005 
 
 Although in the global strategy for the elimination of measles 
(Hall and Jolley, 2011) the vaccination coverage in every district should be 
above 90%, for our country it is clearly seen that this coverage is in very 
high levels, i.e. well above 95%. For the first dose the average value is 
98.8% and with IC [98.4% -99.3%], which shows that vaccination coverage 
is also high at the district level. (Graph.1) 
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 It is worth mentioning that since 2009 the hepatitis B component was 
included in the combined pentavalent DTP-HepB-Hib vaccine. 
 As it is seen even graphically, this coverage is above 95% of the 
value according to WHO recommendations (WHO, 2014), but for our 
country, the average value is  98.3% with IC [98.0% -98.5%], which 
indicates a very high level of coverage with this vaccine, already combined 5 
in 1. 
 
Graph 2. Vaccination coverage for the third dose of hepatitis B, 2003-2013 
 
 Especially considering the last three years, it is noted that vaccination 
coverage with three doses of vaccine containing hepatitis B is at sustainable 
levels (Nelaj et al, 2014) always above 95%, according to the 
recommendations of the WHO, but for our country this value reaches above 
98 %. One of the factors of reaching high levels is the use of the combined 
vaccine 5 in 1, enabling  child vaccination  with only one injection. The other 
reason is that since 2008, the introduction of this vaccine was associated with 
its use in one-vial dose administration, that ia to say, a vaccine to a child. 
Some years ago, mainly in the rural areas, vaccination centers used the 
practice of approximate date of vaccination by assembling children for 
vaccination in one or two days a month, so there was no significant loss in 
the use of the multi-dose bottle; while by using one-dose bottle vaccines  the 
child is  vaccinated almost exactly on the appointed day, with rare 
exceptions, when vaccination is postponed for health reasons. 
 Graphical presentation clearly demonstrates the viability of the 
vaccine in very high levels. 
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Graph 3. Immunization coverage for the three doses of DTP-HepB-Hib, in 2011-2013 
 
 Graph 3 clearly shows that high levels of this coverage are reflected 
by the very high coverage in each district of the country, where the coverage 
values go beyond the 98%. Specifically the average value is 99.2% with IC 
[98.9% -99.5%]. 
 
DTP vaccination coverage for Albania 
 As it was mentioned in the previous evaluation of the coverage for 
other vaccine antigens, in the immunization global strategy (WHO,2016), the 
important factor for vaccine coverage is its value over 95% at the national 
level and at the district level above 90% for the three vaccine doses 
containing diphtheria, tetanus and pertus. 
 For the evaluation of vaccine coverage, the application of the third 
dose with DTP component is taken into consideration, since it means the 
fulfillment of a series of vaccination with this vaccine, according to the 
national immunization schedule. Immunization coverage for three applied 
vaccine doses with DTP component for the years 2003-2013 appears to be 
above 95% at the country and district level. As it was mentined, since 2009, 
DTP components were included in the pentavalent DTP-HepB-Hib 
combined vaccine. 
 It is clearly seen that the level of vaccine coverage for these components 
(Graph 4) exceeds the value of 95%, reaching in some cases 99% values. 
The average value turns out to be 98.3% 




Graph 4. Immunization coverage for DTP components, 2003-2013 
 
 According to the calendar, at the two-month age the revaccination 
with DTP vaccine (diphtheria tetanus, pertus) is applied. Graph 5 shows the 
values of DTP vaccine coverage for the first booster dose. It is obviously 
seen that  at the age of 2 vaccination with this vaccine retains (maintains) the 
same trend, i.e. vaccination coverage, not just 95% but more than 97%. 
 
Graph 5. DTP vaccine coverage, in the first booster dose, during the years 2003-2013 
 
 At the age of 5, according to the immunization calendar, the second 
booster dose with DT (diphtheria tetanus) vaccine is defined 
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Graph 6. Immunization coverage for DT in the second booster dose, during the years 2003-
2013 
 
 Graph 6 shows the immuniztion coverage for DT in the second 
booster dose. Vaccination in this age retains again the same trend, more than 
97%. One strong reason for maintaining these levels is the fact that children 
ought to be vaccinated before staring the primary school; they are strongly 
obliged to present their immunization records before their enrollment in 
schools. 
 At the age of 14, as marked in the calendar, the third booster dose 
(tetanus, with less diphtheria) happens. Graph 7 shows the values of 
Immunization coverage for Td in the third booster dose, during the years 
2003-2013 
 
Graph 7. Immunization coverage for Td in the third booster dose, during the years 2003-
2013 
 




 Immunization coverage for vaccines with measles component 
remains at very high levels for both doses of vaccination. 
 To continue with the same high levels of vaccination coverage for 
MMR component vaccine, these steps should be followed: closely tracking 
and monitoring the vaccination calendar with the two relevant doses of 
MMR vaccine to all children in Albania, strengthening of measles 
surveillance in order to prevent any possible transmission of the disease and 
working to eliminate the receptive pockets, i.e. vaccination of children who 
are still unvaccinated due to parents’ negligence or refusal. 
 Immunization coverage for vaccines with DTP component exceeds 
95%  in the national level, for each district it is above 95% and in the last 
two years, it overpasses the 95% value. During the last years, the vaccine 
coverage has increased significantly as the result of using DTP-HepB-Hib 
pentavelente vaccine. Immunization coverage for Diphtheria-tetanus-pertus 
resulted to be in very high levels, above 95% and in some cases above 98% 
values.  
 Regarding tetanus booster doses, it is recommended that this calendar 
will not only cover children aged 0-14 years, but also adults and the elderly 
ones. In addition, ways of reporting coverage vaccination should also include  
children with backward vaccination. 
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